Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

H Lundbeck A/S (HLUKF)

H Lundbeck A/S (HLUKF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 10.11
  • Price/Book 1.88
Trade HLUKF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.9800 +17.37%
on 05/09/22
24.6250 unch
on 06/08/22
+2.6750 (+12.19%)
since 05/06/22
3-Month
20.9800 +17.37%
on 05/09/22
24.6250 unch
on 06/08/22
+1.3150 (+5.64%)
since 03/08/22
52-Week
20.9800 +17.37%
on 05/09/22
32.4100 -24.02%
on 08/11/21
-5.9150 (-19.37%)
since 06/02/21

Most Recent Stories

More News
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?

The biopharmaceutical company's shares have soared during the past year.

HLUKF : 24.6250 (+6.88%)
AXSM : 69.71 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 25.5383
2nd Resistance Point 25.0817
1st Resistance Point 24.8533
Last Price 24.6250
1st Support Level 24.1683
2nd Support Level 23.7117
3rd Support Level 23.4833

See More

52-Week High 32.4100
Fibonacci 61.8% 28.0437
Fibonacci 50% 26.6950
Fibonacci 38.2% 25.3463
Last Price 24.6250
52-Week Low 20.9800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar